Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pituitary Neoplasms | 53 | 2024 | 1323 | 7.830 |
Why?
|
Adenoma | 48 | 2024 | 2159 | 5.730 |
Why?
|
Pituitary ACTH Hypersecretion | 15 | 2024 | 179 | 3.070 |
Why?
|
Acromegaly | 14 | 2024 | 310 | 2.700 |
Why?
|
ACTH-Secreting Pituitary Adenoma | 10 | 2023 | 63 | 2.570 |
Why?
|
Craniopharyngioma | 9 | 2023 | 276 | 2.550 |
Why?
|
Radiosurgery | 18 | 2024 | 1339 | 2.550 |
Why?
|
Hypopituitarism | 8 | 2022 | 250 | 2.140 |
Why?
|
Somatostatin | 6 | 2020 | 447 | 1.790 |
Why?
|
Thyrotropin | 4 | 2024 | 834 | 1.210 |
Why?
|
Neurosurgical Procedures | 12 | 2021 | 2067 | 1.050 |
Why?
|
Growth Hormone-Secreting Pituitary Adenoma | 6 | 2024 | 49 | 0.980 |
Why?
|
Human Growth Hormone | 9 | 2024 | 642 | 0.960 |
Why?
|
Serum Amyloid A Protein | 1 | 2024 | 126 | 0.920 |
Why?
|
Adrenocorticotropic Hormone | 10 | 2024 | 618 | 0.900 |
Why?
|
CARD Signaling Adaptor Proteins | 1 | 2024 | 159 | 0.850 |
Why?
|
Hypothalamus | 3 | 2023 | 999 | 0.750 |
Why?
|
Neoplasm Recurrence, Local | 13 | 2023 | 9278 | 0.730 |
Why?
|
Endosomal Sorting Complexes Required for Transport | 2 | 2019 | 149 | 0.730 |
Why?
|
Microsurgery | 4 | 2021 | 793 | 0.690 |
Why?
|
Pro-Opiomelanocortin | 5 | 2024 | 140 | 0.670 |
Why?
|
Octreotide | 1 | 2020 | 154 | 0.670 |
Why?
|
Inflammasomes | 1 | 2024 | 525 | 0.650 |
Why?
|
Prolactinoma | 5 | 2023 | 114 | 0.640 |
Why?
|
Ubiquitin Thiolesterase | 2 | 2019 | 455 | 0.630 |
Why?
|
Third Ventricle | 2 | 2016 | 74 | 0.620 |
Why?
|
Endopeptidases | 2 | 2019 | 766 | 0.610 |
Why?
|
Peptides, Cyclic | 1 | 2020 | 392 | 0.610 |
Why?
|
Infratentorial Neoplasms | 1 | 2019 | 98 | 0.600 |
Why?
|
Pituitary Gland | 9 | 2023 | 635 | 0.580 |
Why?
|
Ovarian Hyperstimulation Syndrome | 1 | 2017 | 47 | 0.570 |
Why?
|
Amyloidosis | 1 | 2024 | 864 | 0.550 |
Why?
|
Cerebral Ventricle Neoplasms | 1 | 2016 | 43 | 0.550 |
Why?
|
Receptors, Somatostatin | 4 | 2024 | 137 | 0.550 |
Why?
|
Follicle Stimulating Hormone | 2 | 2017 | 726 | 0.540 |
Why?
|
Prion Diseases | 3 | 2022 | 99 | 0.520 |
Why?
|
Prions | 3 | 2022 | 177 | 0.520 |
Why?
|
Ependymoma | 1 | 2019 | 320 | 0.510 |
Why?
|
Skull Base Neoplasms | 3 | 2018 | 270 | 0.510 |
Why?
|
Insulin-Like Growth Factor I | 4 | 2022 | 1932 | 0.500 |
Why?
|
Pituitary Hormones | 2 | 2013 | 182 | 0.430 |
Why?
|
Meningioma | 4 | 2020 | 1216 | 0.410 |
Why?
|
Treatment Outcome | 34 | 2024 | 64670 | 0.400 |
Why?
|
Cushing Syndrome | 4 | 2022 | 241 | 0.400 |
Why?
|
Zygoma | 1 | 2012 | 52 | 0.390 |
Why?
|
Frontal Bone | 1 | 2012 | 105 | 0.380 |
Why?
|
Hypophysectomy | 3 | 2020 | 114 | 0.370 |
Why?
|
Neoplasm, Residual | 4 | 2019 | 1008 | 0.340 |
Why?
|
Deamino Arginine Vasopressin | 1 | 2009 | 87 | 0.330 |
Why?
|
Retrospective Studies | 28 | 2024 | 80673 | 0.320 |
Why?
|
Optic Nerve Diseases | 2 | 2012 | 342 | 0.320 |
Why?
|
Incidental Findings | 1 | 2013 | 698 | 0.310 |
Why?
|
Orbit | 1 | 2012 | 457 | 0.310 |
Why?
|
Receptors, Glucocorticoid | 2 | 2023 | 304 | 0.300 |
Why?
|
Adult | 48 | 2024 | 221083 | 0.300 |
Why?
|
Sphenoid Bone | 4 | 2021 | 177 | 0.300 |
Why?
|
Anesthesia | 1 | 2019 | 1591 | 0.290 |
Why?
|
Humans | 93 | 2024 | 761098 | 0.290 |
Why?
|
Dacarbazine | 1 | 2010 | 559 | 0.290 |
Why?
|
Ligands | 4 | 2024 | 3266 | 0.290 |
Why?
|
Hormones | 3 | 2023 | 869 | 0.290 |
Why?
|
Decompression, Surgical | 2 | 2012 | 607 | 0.280 |
Why?
|
Temporal Bone | 1 | 2012 | 683 | 0.280 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2010 | 617 | 0.270 |
Why?
|
Spinal Fractures | 2 | 2024 | 704 | 0.270 |
Why?
|
Cranial Irradiation | 4 | 2020 | 390 | 0.270 |
Why?
|
Female | 58 | 2024 | 392458 | 0.250 |
Why?
|
Combined Modality Therapy | 6 | 2021 | 8519 | 0.250 |
Why?
|
Dopamine Agonists | 3 | 2023 | 352 | 0.250 |
Why?
|
Middle Aged | 42 | 2024 | 220835 | 0.250 |
Why?
|
Pituitary Gland, Posterior | 2 | 2016 | 42 | 0.250 |
Why?
|
Male | 55 | 2024 | 360675 | 0.240 |
Why?
|
Prolactin | 3 | 2023 | 625 | 0.240 |
Why?
|
Granular Cell Tumor | 2 | 2016 | 48 | 0.240 |
Why?
|
Hydrocortisone | 6 | 2022 | 1818 | 0.230 |
Why?
|
Vision Disorders | 5 | 2018 | 1088 | 0.230 |
Why?
|
Chordoma | 2 | 2020 | 347 | 0.220 |
Why?
|
Salvage Therapy | 1 | 2010 | 1264 | 0.220 |
Why?
|
Postoperative Period | 4 | 2016 | 1818 | 0.210 |
Why?
|
Inappropriate ADH Syndrome | 1 | 2023 | 61 | 0.210 |
Why?
|
PrPC Proteins | 1 | 2022 | 35 | 0.210 |
Why?
|
Italy | 2 | 2015 | 843 | 0.200 |
Why?
|
Calreticulin | 1 | 2022 | 113 | 0.190 |
Why?
|
Sphenoid Sinus | 2 | 2016 | 99 | 0.190 |
Why?
|
Thyroid Neoplasms | 1 | 2015 | 2331 | 0.190 |
Why?
|
Nelson Syndrome | 1 | 2021 | 20 | 0.190 |
Why?
|
Visual Pathways | 3 | 2024 | 551 | 0.180 |
Why?
|
Sella Turcica | 1 | 2021 | 118 | 0.180 |
Why?
|
Receptors, Somatotropin | 1 | 2020 | 58 | 0.180 |
Why?
|
Antineoplastic Agents | 2 | 2023 | 13630 | 0.180 |
Why?
|
Neuronavigation | 1 | 2021 | 166 | 0.170 |
Why?
|
Follow-Up Studies | 11 | 2024 | 39121 | 0.170 |
Why?
|
Dexamethasone | 3 | 2023 | 1945 | 0.170 |
Why?
|
Craniotomy | 3 | 2021 | 741 | 0.170 |
Why?
|
Prognosis | 6 | 2020 | 29672 | 0.170 |
Why?
|
Luteinizing Hormone | 2 | 2017 | 820 | 0.170 |
Why?
|
Magnetic Resonance Imaging, Interventional | 1 | 2021 | 187 | 0.170 |
Why?
|
Optic Chiasm | 2 | 2018 | 91 | 0.170 |
Why?
|
Organs at Risk | 1 | 2021 | 359 | 0.160 |
Why?
|
Aged | 23 | 2024 | 169266 | 0.160 |
Why?
|
Propensity Score | 2 | 2024 | 1913 | 0.160 |
Why?
|
Oxytocin | 1 | 2023 | 402 | 0.160 |
Why?
|
History, 19th Century | 1 | 2021 | 718 | 0.160 |
Why?
|
Young Adult | 12 | 2023 | 59199 | 0.160 |
Why?
|
Fluorescence | 1 | 2021 | 754 | 0.160 |
Why?
|
Magnetic Resonance Imaging | 14 | 2023 | 36418 | 0.160 |
Why?
|
Adrenalectomy | 1 | 2021 | 346 | 0.160 |
Why?
|
Body Mass Index | 1 | 2016 | 12951 | 0.160 |
Why?
|
Calculi | 1 | 2019 | 48 | 0.160 |
Why?
|
Watchful Waiting | 1 | 2023 | 489 | 0.160 |
Why?
|
Empty Sella Syndrome | 1 | 2018 | 14 | 0.150 |
Why?
|
Encephalocele | 1 | 2019 | 135 | 0.150 |
Why?
|
Chondrosarcoma | 1 | 2020 | 295 | 0.140 |
Why?
|
Cell Differentiation | 1 | 2015 | 11505 | 0.140 |
Why?
|
Myeloproliferative Disorders | 1 | 2022 | 609 | 0.130 |
Why?
|
Quality of Life | 6 | 2023 | 13362 | 0.130 |
Why?
|
Postoperative Complications | 10 | 2023 | 15634 | 0.130 |
Why?
|
Receptors, Corticotropin-Releasing Hormone | 1 | 2016 | 89 | 0.130 |
Why?
|
Delayed Diagnosis | 1 | 2020 | 465 | 0.130 |
Why?
|
Autoantigens | 1 | 2020 | 887 | 0.130 |
Why?
|
Cerebellum | 2 | 2022 | 1501 | 0.120 |
Why?
|
Osteoporosis | 1 | 2024 | 1604 | 0.120 |
Why?
|
Ubiquitination | 1 | 2019 | 1004 | 0.120 |
Why?
|
alpha-Synuclein | 1 | 2021 | 742 | 0.120 |
Why?
|
Hypothyroidism | 3 | 2016 | 668 | 0.120 |
Why?
|
Meningeal Neoplasms | 2 | 2020 | 1246 | 0.120 |
Why?
|
Bone Density | 2 | 2024 | 3548 | 0.120 |
Why?
|
Vision, Ocular | 1 | 2018 | 454 | 0.120 |
Why?
|
Hormone Replacement Therapy | 1 | 2020 | 751 | 0.120 |
Why?
|
Thyroid Function Tests | 1 | 2015 | 288 | 0.110 |
Why?
|
Corticotropin-Releasing Hormone | 4 | 2022 | 361 | 0.110 |
Why?
|
Bone and Bones | 1 | 2024 | 2567 | 0.110 |
Why?
|
Cell Communication | 1 | 2021 | 1650 | 0.110 |
Why?
|
Reoperation | 4 | 2023 | 4304 | 0.110 |
Why?
|
Cerebellar Neoplasms | 1 | 2019 | 586 | 0.110 |
Why?
|
Consensus | 2 | 2020 | 3133 | 0.110 |
Why?
|
Radiotherapy | 1 | 2020 | 1498 | 0.110 |
Why?
|
History, 20th Century | 1 | 2021 | 2764 | 0.110 |
Why?
|
Medulloblastoma | 1 | 2019 | 677 | 0.110 |
Why?
|
Ultrasonography, Interventional | 1 | 2021 | 1496 | 0.110 |
Why?
|
Premenopause | 1 | 2017 | 1038 | 0.110 |
Why?
|
Cranial Fossa, Posterior | 1 | 2013 | 134 | 0.100 |
Why?
|
Adolescent | 13 | 2023 | 88271 | 0.100 |
Why?
|
Practice Guidelines as Topic | 2 | 2020 | 7400 | 0.100 |
Why?
|
Plasmacytoma | 1 | 2013 | 170 | 0.100 |
Why?
|
Azacitidine | 1 | 2014 | 336 | 0.100 |
Why?
|
Enzyme Activators | 1 | 2012 | 57 | 0.100 |
Why?
|
Radiotherapy, Adjuvant | 2 | 2016 | 1784 | 0.100 |
Why?
|
Monitoring, Intraoperative | 1 | 2019 | 943 | 0.100 |
Why?
|
Aminoimidazole Carboxamide | 1 | 2012 | 85 | 0.100 |
Why?
|
Ribonucleotides | 1 | 2012 | 114 | 0.100 |
Why?
|
Adenylate Kinase | 1 | 2012 | 102 | 0.100 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2021 | 2864 | 0.100 |
Why?
|
Adrenal Insufficiency | 1 | 2013 | 194 | 0.100 |
Why?
|
Preoperative Care | 1 | 2020 | 2242 | 0.090 |
Why?
|
Time Factors | 8 | 2020 | 39953 | 0.090 |
Why?
|
Vision Tests | 1 | 2012 | 160 | 0.090 |
Why?
|
Autoantibodies | 1 | 2020 | 2117 | 0.090 |
Why?
|
O(6)-Methylguanine-DNA Methyltransferase | 1 | 2010 | 83 | 0.090 |
Why?
|
Recombinant Proteins | 1 | 2020 | 6507 | 0.090 |
Why?
|
Dura Mater | 1 | 2012 | 290 | 0.080 |
Why?
|
Patient Care Team | 1 | 2020 | 2513 | 0.080 |
Why?
|
Mice, Knockout | 1 | 2024 | 14393 | 0.080 |
Why?
|
Hyperprolactinemia | 2 | 2016 | 124 | 0.080 |
Why?
|
Disease-Free Survival | 3 | 2016 | 6817 | 0.080 |
Why?
|
Child | 9 | 2023 | 80134 | 0.080 |
Why?
|
Case-Control Studies | 4 | 2020 | 22157 | 0.070 |
Why?
|
Referral and Consultation | 1 | 2020 | 3603 | 0.070 |
Why?
|
Pediatrics | 1 | 2023 | 3589 | 0.070 |
Why?
|
Hypogonadism | 1 | 2013 | 798 | 0.070 |
Why?
|
Analysis of Variance | 2 | 2013 | 6224 | 0.070 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2011 | 700 | 0.070 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2010 | 592 | 0.070 |
Why?
|
Ergolines | 1 | 2006 | 57 | 0.070 |
Why?
|
Optic Nerve | 1 | 2009 | 571 | 0.060 |
Why?
|
Mice, Inbred C57BL | 1 | 2024 | 22129 | 0.060 |
Why?
|
Prospective Studies | 5 | 2023 | 54419 | 0.060 |
Why?
|
Endothelin-1 | 1 | 2007 | 301 | 0.060 |
Why?
|
Aged, 80 and over | 5 | 2021 | 58946 | 0.060 |
Why?
|
Cell Proliferation | 3 | 2017 | 10421 | 0.060 |
Why?
|
Magnetic Resonance Angiography | 1 | 2012 | 1432 | 0.060 |
Why?
|
Disease Models, Animal | 1 | 2024 | 18217 | 0.060 |
Why?
|
Clinical Competence | 1 | 2020 | 4786 | 0.060 |
Why?
|
Tumor Cells, Cultured | 3 | 2019 | 6123 | 0.060 |
Why?
|
Brain Neoplasms | 2 | 2020 | 9025 | 0.060 |
Why?
|
Visual Fields | 1 | 2011 | 1059 | 0.060 |
Why?
|
Remission Induction | 1 | 2010 | 2392 | 0.060 |
Why?
|
Inflammation | 1 | 2024 | 10758 | 0.060 |
Why?
|
Cohort Studies | 3 | 2024 | 41486 | 0.060 |
Why?
|
Mice | 4 | 2024 | 81324 | 0.060 |
Why?
|
Recurrence | 2 | 2009 | 8456 | 0.060 |
Why?
|
Obesity | 2 | 2023 | 12937 | 0.060 |
Why?
|
Intracranial Hypertension | 1 | 2006 | 193 | 0.050 |
Why?
|
Antibodies | 2 | 2022 | 2415 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 6482 | 0.050 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2018 | 8529 | 0.050 |
Why?
|
Visual Acuity | 1 | 2012 | 2677 | 0.050 |
Why?
|
Animals | 6 | 2024 | 168083 | 0.050 |
Why?
|
Genome-Wide Association Study | 1 | 2021 | 12670 | 0.050 |
Why?
|
HMGA2 Protein | 1 | 2002 | 101 | 0.050 |
Why?
|
Proportional Hazards Models | 2 | 2013 | 12467 | 0.050 |
Why?
|
Positron-Emission Tomography | 1 | 2018 | 6585 | 0.050 |
Why?
|
Odds Ratio | 1 | 2013 | 9648 | 0.050 |
Why?
|
Thyroid Hormones | 1 | 2004 | 403 | 0.050 |
Why?
|
Anesthesia Recovery Period | 1 | 2002 | 155 | 0.050 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2007 | 3512 | 0.050 |
Why?
|
Mutation | 3 | 2022 | 30006 | 0.050 |
Why?
|
Insulin | 2 | 2007 | 6588 | 0.040 |
Why?
|
Ribonucleoproteins | 1 | 2022 | 356 | 0.040 |
Why?
|
Multivariate Analysis | 1 | 2013 | 12058 | 0.040 |
Why?
|
Sheep | 1 | 2022 | 1436 | 0.040 |
Why?
|
Dose-Response Relationship, Radiation | 2 | 2012 | 880 | 0.040 |
Why?
|
Thoracic Vertebrae | 1 | 2024 | 612 | 0.040 |
Why?
|
Acyltransferases | 1 | 2021 | 305 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 5 | 2019 | 20600 | 0.040 |
Why?
|
Labial Frenum | 1 | 2019 | 6 | 0.040 |
Why?
|
Hydrocephalus | 1 | 2006 | 764 | 0.040 |
Why?
|
Carcinoma | 1 | 2010 | 2328 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15308 | 0.040 |
Why?
|
Glucose | 3 | 2019 | 4341 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2023 | 1702 | 0.040 |
Why?
|
Endoscopy | 2 | 2023 | 1852 | 0.040 |
Why?
|
Pregnancy Complications | 1 | 2012 | 2948 | 0.040 |
Why?
|
Molecular Chaperones | 1 | 2022 | 754 | 0.040 |
Why?
|
Homozygote | 1 | 2022 | 1775 | 0.040 |
Why?
|
Age Factors | 2 | 2020 | 18385 | 0.040 |
Why?
|
Risk Factors | 2 | 2024 | 74219 | 0.030 |
Why?
|
Mammals | 1 | 2022 | 1131 | 0.030 |
Why?
|
Benchmarking | 1 | 2023 | 1045 | 0.030 |
Why?
|
Incidence | 1 | 2015 | 21357 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2014 | 11856 | 0.030 |
Why?
|
Antigens, Polyomavirus Transforming | 1 | 2017 | 257 | 0.030 |
Why?
|
Diagnosis, Differential | 3 | 2022 | 12975 | 0.030 |
Why?
|
Prevalence | 2 | 2024 | 15717 | 0.030 |
Why?
|
Trans-Activators | 1 | 2005 | 2846 | 0.030 |
Why?
|
Lysosomes | 1 | 2021 | 920 | 0.030 |
Why?
|
Glucose Tolerance Test | 1 | 2019 | 1178 | 0.030 |
Why?
|
Diabetes Insipidus | 1 | 2016 | 144 | 0.030 |
Why?
|
Gynecomastia | 1 | 2016 | 86 | 0.030 |
Why?
|
Sex Factors | 2 | 2020 | 10552 | 0.030 |
Why?
|
Skull | 1 | 2019 | 818 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2020 | 1187 | 0.030 |
Why?
|
Brain | 2 | 2021 | 27097 | 0.030 |
Why?
|
RNA Interference | 1 | 2022 | 2816 | 0.030 |
Why?
|
Drosophila melanogaster | 1 | 2022 | 1711 | 0.030 |
Why?
|
RNA, Small Interfering | 1 | 2022 | 3409 | 0.030 |
Why?
|
Piperidines | 1 | 2002 | 1656 | 0.030 |
Why?
|
Heterozygote | 1 | 2020 | 2778 | 0.030 |
Why?
|
Gene Expression Profiling | 2 | 2019 | 9416 | 0.030 |
Why?
|
14-alpha Demethylase Inhibitors | 1 | 2012 | 4 | 0.030 |
Why?
|
Proteome | 1 | 2022 | 1856 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2013 | 11732 | 0.030 |
Why?
|
Ketoconazole | 1 | 2012 | 97 | 0.020 |
Why?
|
Telomerase | 1 | 2017 | 741 | 0.020 |
Why?
|
Gene Transfer Techniques | 1 | 2017 | 1201 | 0.020 |
Why?
|
Term Birth | 1 | 2012 | 138 | 0.020 |
Why?
|
Abruptio Placentae | 1 | 2012 | 118 | 0.020 |
Why?
|
Administration, Oral | 1 | 2019 | 4014 | 0.020 |
Why?
|
Homeostasis | 1 | 2021 | 3318 | 0.020 |
Why?
|
Heart Rate | 1 | 2002 | 4196 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 613 | 0.020 |
Why?
|
Gonadotropins | 1 | 2011 | 241 | 0.020 |
Why?
|
Survival Analysis | 1 | 2002 | 10083 | 0.020 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2018 | 2025 | 0.020 |
Why?
|
Down-Regulation | 1 | 2016 | 2915 | 0.020 |
Why?
|
Recovery of Function | 1 | 2019 | 2981 | 0.020 |
Why?
|
Nerve Compression Syndromes | 1 | 2009 | 160 | 0.020 |
Why?
|
Child, Preschool | 2 | 2023 | 42217 | 0.020 |
Why?
|
Gene Expression | 2 | 2016 | 7567 | 0.020 |
Why?
|
Proteins | 1 | 2002 | 5993 | 0.020 |
Why?
|
Visual Field Tests | 1 | 2009 | 410 | 0.020 |
Why?
|
Abortion, Spontaneous | 1 | 2012 | 532 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2020 | 4744 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2012 | 3577 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2016 | 2160 | 0.020 |
Why?
|
Risk Assessment | 1 | 2008 | 24013 | 0.020 |
Why?
|
Blood Pressure | 1 | 2002 | 8478 | 0.020 |
Why?
|
Cyclic GMP | 1 | 2007 | 395 | 0.020 |
Why?
|
Analgesics, Opioid | 1 | 2002 | 3808 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10514 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2011 | 2855 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2018 | 7043 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2011 | 3419 | 0.010 |
Why?
|
Immunotherapy | 1 | 2020 | 4642 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 2012 | 1967 | 0.010 |
Why?
|
Radiotherapy Dosage | 1 | 2011 | 2898 | 0.010 |
Why?
|
Disease Progression | 1 | 2021 | 13506 | 0.010 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2012 | 1655 | 0.010 |
Why?
|
Keto Acids | 1 | 2002 | 34 | 0.010 |
Why?
|
Cell Survival | 1 | 2012 | 5776 | 0.010 |
Why?
|
Labetalol | 1 | 2002 | 29 | 0.010 |
Why?
|
Secretory Vesicles | 1 | 2003 | 127 | 0.010 |
Why?
|
Phosphorylation | 1 | 2012 | 8303 | 0.010 |
Why?
|
Paraneoplastic Syndromes | 1 | 2003 | 155 | 0.010 |
Why?
|
Nitrous Oxide | 1 | 2002 | 166 | 0.010 |
Why?
|
Leucine | 1 | 2002 | 547 | 0.010 |
Why?
|
Hedgehog Proteins | 1 | 2005 | 769 | 0.010 |
Why?
|
DNA Methylation | 1 | 2014 | 4386 | 0.010 |
Why?
|
Aging | 1 | 2019 | 8701 | 0.010 |
Why?
|
Cause of Death | 1 | 2011 | 3688 | 0.010 |
Why?
|
Karyotyping | 1 | 2002 | 1171 | 0.010 |
Why?
|
Drainage | 1 | 2006 | 1158 | 0.010 |
Why?
|
Glutamine | 1 | 2002 | 574 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 2003 | 2562 | 0.010 |
Why?
|
Isoflurane | 1 | 2002 | 384 | 0.010 |
Why?
|
Nitric Oxide | 1 | 2007 | 2135 | 0.010 |
Why?
|
Gene Amplification | 1 | 2002 | 1084 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2007 | 3210 | 0.010 |
Why?
|
Linear Models | 1 | 2007 | 5869 | 0.010 |
Why?
|
Anesthetics, Inhalation | 1 | 2002 | 572 | 0.010 |
Why?
|
Survival Rate | 1 | 2011 | 12727 | 0.010 |
Why?
|
Amino Acids | 1 | 2002 | 1703 | 0.010 |
Why?
|
Rats | 1 | 2012 | 23713 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 2005 | 2802 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2002 | 2508 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2007 | 4340 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2007 | 3821 | 0.010 |
Why?
|
Respiration | 1 | 2002 | 1656 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2002 | 4565 | 0.010 |
Why?
|
Body Composition | 1 | 2002 | 2427 | 0.010 |
Why?
|
Antihypertensive Agents | 1 | 2002 | 2019 | 0.010 |
Why?
|
Pregnancy | 1 | 2012 | 29872 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2005 | 11118 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2005 | 16947 | 0.000 |
Why?
|
Insulin Resistance | 1 | 2002 | 3951 | 0.000 |
Why?
|
Membrane Proteins | 1 | 2005 | 7844 | 0.000 |
Why?
|